Peter L Fisher PhD (University of Dundee)
Reader, University of Liverpool, Liverpool · United Kingdom
Editorial leadership for Journal of Cognitive Behavioral Therapy
Research interests
- Clinical Psychology
Biography
Dr. Peter L. Fisher is a Reader at the University of Liverpool, United Kingdom, where he conducts research on metacognitive therapy and emotional distress in physical illness. He earned his PhD from the University of Dundee and has established himself as a leading expert in metacognitive approaches to psychological disorders, particularly obsessive-compulsive disorder, anxiety, and depression in medical populations. His most influential work, a 2022 systematic review and meta-analysis on fear of cancer recurrence in cancer survivors and patients, has been cited 289 times and reflects his sustained focus on improving psychological interventions for individuals facing serious physical health challenges. Dr. Fisher has delivered keynote addresses at major international conferences on metacognitive therapy and has been invited to present workshops and lectures at institutions across Europe, Australia, and beyond, demonstrating the global reach and clinical impact of his research.
Selected publications
- What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta‐analysis 2022 cited 289×
- Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY—A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy 2021 cited 88×
- Understanding the identity of lived experience researchers and providers: a conceptual framework and systematic narrative review 2023 cited 65×
- Metacognitive Therapy for Emotional Distress in Adult Cancer Survivors: A Case Series 2017 cited 31×
- Clinical utility of the Metacognitions Questionnaire 30 in people with epilepsy 2016 cited 28×
- Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial 2023 cited 22×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCBT for your work?
This journal is guided by Peter L Fisher (Reader, University of Liverpool, Liverpool) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.